17th International Conference on
Pathology & Cancer Epidemiology
October 08-09, 2018 | Edinburgh, Scotland
Pathology Market Overview
Pathology is the causal
study of the diseases by examining the body tissues sample (e.g.
biopsies/pap smears) and body fluids (e.g. blood/urine etc.). It creates
a bridge between the health science and medicine. Pathology
cover every aspect of the patients care, starting from diagnostics to
treatment advices and prevention. In general, Pathologists work with
physicians, scientists, nurses and healthcare professionals in hospitals
and GPs’ surgeries to diagnose, prevent and treat illness. The whole
segments of pathology comprise of more than 20 different disciplines
starting from general disciplines like cytopathology, histopathology, chemical pathology, hematopathology, anatomical pathology, medical microbiology to more advanced digital pathology.
The global Digital Pathology
market worth about $1.98bn in 2012 and is expected to hit $5.7 billion
by 2020. Automation of the conventional pathology methods is the major
driving force for this market, which leads to the improvements in
workflow efficiency, efficiency in analysis. The other driving factor
include fast and accuracy in results, availability of diagnostics
facilities in the remote areas, cost reductions, reduction in
procedural cost starting from delivery of slide to data. The major
drawback is the strict regulatory approval process for the digital
pathology systems. The other limiting factors are: digital pathology system integration
cost, and standardization of technology and data interpretation format
among countries. The Whole slide imaging (WSI) is the highest revenue
generating segment in this arena with the highest growth potential.
It is estimated that the Europe Digital Pathology
Market to hit $151m by 2021 from $62.3m in 2012. During the same
period, the USA Digital Pathology Market will reach $205.67mn from
$77.23mn at a CAGR of 17%. Among all the countries, North America will
dominate the Digital Pathology market followed by Europe, Latin America
and Asia Pacific. Asia Pacific will witness the fastest growth (at a
CAGR of 13.4%) during the forecast period. Growth will be supported by
the increased number of cancer patients, increased demand of novel
patient care facilities and reduced laboratory expenses.
Anatomic Pathology plays a key role towards the study, diagnosis and treatment of various chronic diseases such as infectious diseases and Cancer. It includes the analysis of biopsy or body parts to diagnose a disease. It is also very important in Pharmaceutical Industries to perform toxicological studies. This Anatomic Pathology market has a huge growth potential fueled by the increased prevalence of chronic diseases, increased aging population and moreover increased health care expenditures across the globe. The global Anatomic pathology market can be segmented into products type and service. The Pathology service market can be segmented into reagents, consumables, instruments, and services. The instruments can be segmented into slide strainers, tissue processers, microtomes, and application market can be segmented to drug discovery, diagnosis. Products in terms of users’ ca be segmented into Diagnostic Laboratories, hospitals, and Research organizations.
The Anatomic Pathology market
is dominated by the North America, followed by Europe, and Asia. These
growth is attributed to the rapid increase in chronic disease
prevalence, increasing aging population, growing demand of personalized medicine, presence of big market and huge investment of both government and private bodies. The Anatomic Market valued about $16.2bn in 2016 with the potential to reach to $21.9bn by 2021 at a CAGR of 6.1%.
Global Anatomic Pathology Market Value ($bn), 2016-2021
In the United Kingdom (UK) there are 570 Laboratories with Clinical Pathology Accreditation, of which 123 are in London and 35 are in Scotland only (As of August 30, 2017).
The purpose of this letter is to invite you for 17th International Conference on
Pathology & Cancer Epidemiology which is going to be held during Oct 08-09, 2018
at Edinburgh, Scotland around the Theme: "Pathology: Current
trends, Advancements, and Emerging Challenges". The
scientific-program will be a rich mix of formats ranging from keynote
sessions featuring many well-known and thought-provoking speakers to intense
and highly interactive discussion sessions
|
For more information you can have a look at Pathology
Conferences
|
Conference highlights:
• Opportunity to attend the presentations delivered by Eminent Scientists from all over the world • Best poster presentations and Young scientist awards • Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging Ideas • Conference brings together Scientific Researchers & Business Entrepreneurs and Issues in Pathology |
Please let me know if you will be able to attend.
Awaiting your early response. |
EuroSciCon Ltd
40 Bloomsbury Way
Lower Ground Floor
London, United Kingdom
WC1A 2SE
E: pathology@eurosciconconferences.com |
No comments:
Post a Comment